Laura Pala

Dr. Laura Pala

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Redox Biology
Verified
Journal Article
Open access
TBTimothy E. Beach
Timothy E. Beach
HPHiran A. Prag
Hiran A. Prag
LPLaura Pala
Laura Pala
ALAngela Logan
Angela Logan
MHMargaret M. Huang
Margaret M. Huang
KSKourosh Saeb-Parsy
Kourosh Saeb-Parsy
Renal ischemia reperfusion (IR) injury leads to significant patient morbidity and mortality, and its amelioration is an urgent unmet clinical need. Succinate accumulates during ischemia and its oxidation by the mitochondrial enzyme succinate dehydrogenase (SDH) drives the ROS production that underlies IR injury. Consequently, compounds that inhibit SDH may have therapeutic potential against renal IR injury. Among these, the competitive SDH inhibitor malonate, administered as a cell-permeable malonate ester prodrug, has shown promise in models of cardiac IR injury, but the efficacy of malonate ester prodrugs against renal IR injury have not been investigated. Here we show that succinate accumulates during ischemia in mouse, pig and human models of renal IR injury, and that its rapid oxidation by SDH upon reperfusion drives IR injury. We then show that the malonate ester prodrug, dimethyl malonate (DMM), can ameliorate renal IR injury when administered at reperfusion but not prior to ischemia in the mouse. Finally, we show that another malonate ester prodrug, diacetoxymethyl malonate (MAM), is more potent than DMM because of its faster esterase hydrolysis. Our data show that the mitochondrial mechanisms of renal IR injury are conserved in the mouse, pig and human and that inhibition of SDH by ‘tuned’ malonate ester prodrugs, such as MAM, is a promising therapeutic strategy in the treatment of clinical renal IR injury.

13 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LPLaura Pala
Laura Pala
TSTeja Sirec
Teja Sirec
USUrs Spitz
Urs Spitz
The ability to detect, identify and quantify bacteria is crucial in clinical diagnostics, environmental testing, food security settings and in microbiology research. Recently, the threat of multidrug-resistant bacterial pathogens pushed the global scientific community to develop fast, reliable, specific and affordable methods to detect bacterial species. The use of synthetically modified enzyme substrates is a convenient approach to detect bacteria in a specific, economic and rapid manner. The method is based on the use of specific enzyme substrates for a given bacterial marker enzyme, conjugated to a signalogenic moiety. Following enzymatic reaction, the signalophor is released from the synthetic substrate, generating a specific and measurable signal. Several types of signalophors have been described and are defined by the type of signal they generate, such as chromogenic, fluorogenic, luminogenic, electrogenic and redox. Signalophors are further subdivided into groups based on their solubility in water, which is key in defining their application on solid or liquid media for bacterial culturing. This comprehensive review describes synthetic enzyme substrates and their applications for bacterial detection, showing their mechanism of action and their synthetic routes.

15 May 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
LPLaura Pala
Laura Pala
SMSamuel Mabbott
Samuel Mabbott
KFK. Faulds
K. Faulds
MBM. A. Bedics
M. A. Bedics
MDM. R. Detty
M. R. Detty
DGD. Graham
D. Graham
12 new Raman active dyes are reported to increase the SERS intensity upon hybridisation of a targeted DNA to oligonucleotide-NP conjugates and can be potentially used together in a multiplex.

6 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
GSGünter Schabert
Günter Schabert
RHRobert Haase
Robert Haase
JPJaclyn Parris
Jaclyn Parris
LPLaura Pala
Laura Pala
ABAdrian Hery Barranco
Adrian Hery Barranco
USUrs Spitz
Urs Spitz
NR+ is a highly effective vitamin B3 type supplement due to its unique ability to replenish NAD+ levels. While NR+ chloride is already on the market as a nutritional supplement, its synthesis is challenging, expensive, and low yielding, making it cumbersome for large-scale industrial production. Here we report the novel crystalline NR+ salts, d/l/dl-hydrogen tartrate and d/l/dl-hydrogen malate. Their high-yielding, one-pot manufacture does not require specific equipment and is suitable for multi-ton scale production. These new NR+ salts seem ideal for nutritional applications due to their bio-equivalence compared to the approved NR+ chloride. In addition, the crystal structures of all stereoisomers of NR+ hydrogen tartrate and NR+ hydrogen malate and a comparison to the known NR+ halogenides are presented.